Glioma is the most common primary malignant
brain tumor with a poor prognosis. The application of chemotherapeutic drugs is limited due to the existence of blood-brain barrier and serious side effects.
Liposomes have been proven to be a stable and useful drug delivery system for
tumors. In this paper, WGA (
wheat germ agglutinin) modified
vinorelbine cationic
liposomes had been successfully constructed for treating
glioma. In the
liposomes, WGA was modified on the liposomal surface for crossing the blood-brain barrier and increasing the targeting effects, 3-(N-(N', N'-dimethylaminoethane) carbamoyl)
cholesterol (
DC-Chol) was used as cationic material and
vinorelbine was encapsulated in the aqueous core of
liposomes to inhibit
tumor metastasis and kill
tumor cells. Studies were performed on C6 cells in vitro and were verified in brain
glioma-bearing mice in vivo. Results in vitro demonstrated that the targeting
liposomes could induce C6 cells apoptosis, promote drugs across the blood-brain barrier, inhibit the
metastasis of
tumor cells and increase targeting effects to
tumor cells. Meanwhile, action mechanism studies showed that the targeting
liposomes could down-regulate PI3K, MMP-2, MMP-9 and FAK to inhibit
tumor metastasis. Results in vivo exhibited that the targeting
liposomes displayed an obvious antitumor efficacy by accumulating selectively in
tumor site and exhibited low toxicity to blood system and major organs. Hence, WGA modified
vinorelbine cationic
liposomes might provide a safe and efficient
therapy strategy for
glioma.